Cotler S J, Jakate S, Jensen D M
Section of Hepatology, RUSH-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA.
J Clin Gastroenterol. 2001 May-Jun;32(5):428-30. doi: 10.1097/00004836-200105000-00014.
Successful therapy for liver diseases, including autoimmune hepatitis, primary biliary cirrhosis, and hepatitis C, has been associated with a reduction in hepatic fibrosis. Recently, a study of needle liver biopsy specimens documented resolution of cirrhosis in a small group of patients with autoimmune hepatitis who responded to corticosteroid therapy. We describe a woman with autoimmune hepatitis who had cirrhosis on a wedge biopsy of the liver in 1985 and who attained a biochemical response with immunosuppressive therapy. A repeat wedge liver biopsy performed 14 years later was normal, providing unequivocal evidence that cirrhosis can reverse completely in autoimmune hepatitis.
包括自身免疫性肝炎、原发性胆汁性肝硬化和丙型肝炎在内的肝脏疾病的成功治疗与肝纤维化的减轻相关。最近,一项针对肝脏穿刺活检标本的研究记录了一小部分对皮质类固醇治疗有反应的自身免疫性肝炎患者的肝硬化消退情况。我们描述了一名自身免疫性肝炎女性患者,她在1985年肝脏楔形活检时患有肝硬化,经免疫抑制治疗后获得了生化反应。14年后进行的重复肝脏楔形活检结果正常,明确证明了自身免疫性肝炎中的肝硬化可以完全逆转。